These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7034022)

  • 1. Platelets of spontaneously hypertensive rats are not abnormally sensitive to PGI2.
    Botha JH; Leary WP
    Prostaglandins Med; 1981 Dec; 7(6):499-500. PubMed ID: 7034022
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandins.
    Sinzinger H; Fitscha P; Kaliman J
    Prostaglandins Leukot Med; 1982 Sep; 9(3):301-5. PubMed ID: 6752958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
    Takano S; Itagaki S; Sakurai K; Suzuki T
    Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH; Reddy KR; White JG
    Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of PGI2 production by isolated perfused rat lungs with platelet aggregation test.
    Hartiala J; Toivonen H; Uotila P
    Prostaglandins; 1980 Jul; 20(1):127-34. PubMed ID: 6996035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-platelet aggregating and disaggregating activities of 6,9-methano PGI2.
    Morita A; Mori M; Hasegawa K; Kojima K; Kobayashi S
    Life Sci; 1980 Aug; 27(8):695-701. PubMed ID: 6997669
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose aspirin (ASA) renders human platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2).
    Philp RB; Paul ML
    Prostaglandins Leukot Med; 1983 Jun; 11(2):131-42. PubMed ID: 6348804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
    Oyekan AO; Botting JH
    Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin I2 (PG I2) fails to inhibit ADP induced platelet aggregation in vivo in rats.
    Zehl U; Förster W
    Prostaglandins Leukot Med; 1984 Oct; 16(1):45-56. PubMed ID: 6393144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.
    Hardwick RA; Hellums JD; Peterson DM; Moake JL; Olson JD
    Blood; 1981 Oct; 58(4):678-81. PubMed ID: 7023570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
    Malmsten C; Claesson HE; Fried J
    Prostaglandins Med; 1980 Jun; 4(6):453-63. PubMed ID: 6251494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.